Nov 23, 2024, 13:54
Young Lung Cancer Initiative – Thanks to research, targeted therapies are transforming lung cancer care
Young Lung Cancer Initiative shared on LinkedIn:
“Thanks to research, targeted therapies are transforming lung cancer care. For people with specific mutations like EGFR, ALK, ROS1, and others, these therapies offer not only better results, but also a much better quality of life.
Take Melanie – living with EGFR lung cancer in England. Melanie says that she can not only lead a normal life, but have hope that further advances will continue to see increased survival rates for others. ”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 23, 2024, 12:11
Dec 23, 2024, 12:00
Dec 23, 2024, 11:45
Dec 23, 2024, 11:41
Dec 23, 2024, 06:21
Dec 23, 2024, 06:08
Dec 23, 2024, 06:05
Dec 23, 2024, 06:00